| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/26/1993 | EP0527891A4 Biodegradable polyesters for sustained drug delivery |
| 05/26/1993 | EP0435915B1 Compositions for the treatment of leishmaniasis |
| 05/26/1993 | CN1072416A Base for film-coating pharmaceuticals and method for preparing same |
| 05/26/1993 | CN1020852C New pharmaceutical preparation for oral use |
| 05/25/1993 | US5214159 Meso-lactide |
| 05/25/1993 | US5214052 Method for dissolving arginineamides and pharmaceutical compositions containing them |
| 05/25/1993 | US5214035 Animal antifertility agents, altrenogest |
| 05/25/1993 | US5213810 Stable compositions for parenteral administration and method of making same |
| 05/25/1993 | US5213806 And cellulose derivative, laxative, antidiarrhea agent |
| 05/25/1993 | US5213804 Localized delivery of antibiotic to tumor via bloodstream, encapsulation in liposome |
| 05/25/1993 | US5213802 Pharmaceutical formulations employing esterified alkoxylated polyols as vehicles |
| 05/25/1993 | CA1318253C Stabilized pergolide compositions |
| 05/25/1993 | CA1318250C Composition for delivery of orally administered drugs and other substances |
| 05/25/1993 | CA1318249C Sustained release compositions for parenteral administration and their use |
| 05/22/1993 | CA2083109A1 Encapsulated particles useful as contrast agents in ultrasound and x-ray imaging compositions and methods |
| 05/21/1993 | CA2083296A1 Composition of matter |
| 05/21/1993 | CA2082352A1 Method for entrapment of active materials in chitosan |
| 05/19/1993 | EP0542364A1 Controlled release device |
| 05/19/1993 | EP0542356A1 (Quinolin-2-ylmethoxy) indole/cyclodextrin complex as leukotrien inhibitor |
| 05/19/1993 | EP0541984A1 Hetero-branched cyclodextrins and method of preparing them |
| 05/19/1993 | EP0541858A1 Cream containing aluminum potassium sulfate and process for preparing same |
| 05/19/1993 | EP0541830A1 Absorption base containing sucrose ester |
| 05/19/1993 | EP0541719A1 New carbohydrate-based anti-inflammatory agents |
| 05/19/1993 | EP0541556A1 Stabilization of biological macromolecular substances and other organic compounds |
| 05/19/1993 | DE4238263A1 Adhesive comprising hydrogel and crosslinked polyvinyl:lactam - is used in electrodes for biomedical application providing low impedance and good mechanical properties when water and/or moisture is absorbed from skin |
| 05/19/1993 | CN1072061A Stable antimicrobial dialdehyde composition and methods of use |
| 05/19/1993 | CN1020733C Process for preparing covalent conjunct agent of bacterial polysaccharide and immunogen protein |
| 05/18/1993 | US5212298 Method for producing synthetic N-linked glycoconjugates |
| 05/18/1993 | US5212290 Monoclonal and polyclonal antibodies |
| 05/18/1993 | US5212199 Sorbitan esters as skin permeation enhancers |
| 05/18/1993 | US5212162 Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| 05/18/1993 | US5212075 Compositions and methods for introducing effectors to pathogens and cells |
| 05/18/1993 | US5211959 Processes for producing slow-release powders |
| 05/18/1993 | US5211955 Pharmaceutical composition containing a hydrophilic active compound, treated with an organic acid and encapsulated in a liposome |
| 05/18/1993 | US5211951 Drug delivery |
| 05/18/1993 | US5211950 Stabilized calcitonin pharmaceutical composition |
| 05/18/1993 | US5211937 Method of determining a site of inflammation utilizing elam-1 ligands |
| 05/18/1993 | US5211827 Electrochemical cell with ionic semiconductor separator |
| 05/18/1993 | CA1318078C Ion exchange resins loaded with quinolonecarboxylic acid derivatives, their preparation and use |
| 05/18/1993 | CA1317899C Stabilization of antibodies |
| 05/18/1993 | CA1317883C Liquid dosage form for oral administration of a pharmaceutically active substance |
| 05/16/1993 | WO1993009783A1 Anti-inflammatory and analgesic plaster |
| 05/16/1993 | CA2121603A1 Antiphlogistic-analgesic plaster |
| 05/13/1993 | WO1993009222A2 Transfection of vertebrate cells e.g. by homologous recombination |
| 05/13/1993 | WO1993009176A2 Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release |
| 05/13/1993 | WO1993009143A1 Production and use of multimeric hemoglobins |
| 05/13/1993 | WO1993009130A1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 05/13/1993 | WO1993008908A1 Method for producing nanocapsules with cross-linked protein-based walls, nanocapsules thereby obtained, and cosmetic, pharmaceutical and food compositions using same |
| 05/13/1993 | WO1993008842A1 Hemoglobins as drug delivery agents |
| 05/13/1993 | WO1993008841A1 Skin permeation enhancer compositions |
| 05/13/1993 | WO1993008840A1 Absorption base containing sucrose ester |
| 05/13/1993 | WO1993008838A1 Oral pharmaceutical composition containing polyethylene glycol immunoglobulin conjugate |
| 05/13/1993 | WO1993008837A1 Stabilised antibodies |
| 05/13/1993 | WO1993008832A1 Stabilization of human interferon |
| 05/13/1993 | WO1993008825A1 Pdgf gel formulation |
| 05/13/1993 | WO1993008804A1 Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration |
| 05/13/1993 | WO1993008798A1 Pentadimine transdermal composition and patch |
| 05/13/1993 | WO1993008699A1 Water-soluble delivery systems for hydrophobic liquids |
| 05/13/1993 | WO1993008688A1 Method and composition for treating tumors having high tyrosinase activity |
| 05/13/1993 | CA2123007A1 Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration |
| 05/13/1993 | CA2122991A1 Transfection of vertebrate cells by homologous recombination |
| 05/13/1993 | CA2122374A1 Oral pharmaceutical composition containing polyethylene glycol immunoglobulin conjugate for reconstitution of secretory immunity and method of reconstituting secretory immunity |
| 05/13/1993 | CA2122260A1 Method for producing nanocapsules with cross-linked protein-based walls, nanocapsules thereby obtained, and cosmetic, pharmaceutical and food compositions using same |
| 05/13/1993 | CA2121129A1 Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release |
| 05/13/1993 | CA2120944A1 Stabilization of human interferon |
| 05/12/1993 | EP0541511A2 Siloxan-containing derivatives of polysaccharides and their use in making paper |
| 05/12/1993 | EP0541369A1 An aqueous dispersion of enteric polymers and a method for producing the same |
| 05/12/1993 | EP0540969A2 Derivatives of structurally modified VIP and pharmaceutical compositions containing them |
| 05/12/1993 | EP0540859A1 Anthracycline prodrugs |
| 05/12/1993 | EP0540751A1 Steroid compound combined with polysaccharide |
| 05/12/1993 | EP0540747A1 Medicine for intraocular operation |
| 05/12/1993 | EP0540670A1 Novel polyamines and method for preparation thereof. |
| 05/12/1993 | EP0540631A1 Trans-mucosal drug preparations and trans-mucosal administration |
| 05/12/1993 | EP0540612A1 Heterobifunctional reagents and conjugates with oxaalkylene units for amphiphilic bridge structures |
| 05/12/1993 | EP0540580A1 Polymeric drug delivery system. |
| 05/12/1993 | EP0538268A4 Targeted protection from cytotoxins |
| 05/12/1993 | EP0303713B1 Percutaneous absorption promoter and dermatologic preparation for external use |
| 05/12/1993 | CN1071845A Injectable extended release formulations and methods |
| 05/12/1993 | CN1071832A Pressurised aerosol compositions |
| 05/12/1993 | CN1020605C Process for preparing azacycloparaffin derivatives |
| 05/11/1993 | US5210133 For hydroxyl functional active components, cosmetics, hair conditioners, effective water solubility or oil solubility, lanolin, cholesterol, vitamins A, D, E |
| 05/11/1993 | US5210102 Emollient durability enhancing siloxanes |
| 05/11/1993 | US5210099 Analgesic compositions |
| 05/11/1993 | US5210083 Aqueous solutions containing taurolidine or taurultam and polyol; bactericides |
| 05/11/1993 | US5210076 Methods of treating Parkinson's disease using melanin |
| 05/11/1993 | US5210074 Method for preparing a dried composition of insulin-like growth factor i |
| 05/11/1993 | US5209932 Foot care compositions |
| 05/11/1993 | US5209931 Stabilized pvc products and their production |
| 05/11/1993 | US5209926 Aminosteroids for ophthalmic use |
| 05/11/1993 | US5209923 Microporous cellulose powders |
| 05/11/1993 | US5209922 Undecylenic acid salt of quaternized copolymer of vinylpyrrolidone and aminoalkylacrylamide |
| 05/11/1993 | US5209720 Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes |
| 05/11/1993 | CA1317550C Dosage form for treating cardiovascular diseases |
| 05/11/1993 | CA1317548C Freeze-dried pharmaceutical preparations for parenteral use |
| 05/11/1993 | CA1317547C Anhydrous application form of low molecular alkali huminates |
| 05/06/1993 | DE4210711A1 Transdermale therapeutische systeme mit kristallisationsinhibitoren Transdermal therapeutic systems with crystallization inhibitors |
| 05/05/1993 | EP0540506A2 Organosiloxane-containing polysaccharides |
| 05/05/1993 | EP0540460A1 Novel saccharide-based matrix |
| 05/05/1993 | EP0540357A2 Protein-silicone copolymers and compositions containing them |
| 05/05/1993 | EP0539751A1 Biodegradable polymer composition |